Cardiol Therapeutics Inc. (CRDL)

Cardiol Therapeutics Statistics

Total Valuation

CRDL has a market cap or net worth of $109.41 million. The enterprise value is $96.46 million.

Market Cap	109.41M
Enterprise Value	96.46M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CRDL has 94.73 million shares outstanding. The number of shares has increased by 18.77% in one year.

Current Share Class	94.73M
Shares Outstanding	94.73M
Shares Change (YoY)	+18.77%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	3.46%
Owned by Institutions (%)	9.03%
Float	91.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.64
P/TBV Ratio	12.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.01.

Current Ratio	2.46
Quick Ratio	2.30
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -276.41% and return on invested capital (ROIC) is -183.05%.

Return on Equity (ROE)	-276.41%
Return on Assets (ROA)	-108.74%
Return on Invested Capital (ROIC)	-183.05%
Return on Capital Employed (ROCE)	-337.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.06% in the last 52 weeks. The beta is 0.62, so CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-39.06%
50-Day Moving Average	1.10
200-Day Moving Average	1.19
Relative Strength Index (RSI)	56.25
Average Volume (20 Days)	835,230

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.50M
Pretax Income	-27.53M
Net Income	-27.53M
EBITDA	-29.46M
EBIT	-29.50M
Earnings Per Share (EPS)	-$0.35

Balance Sheet

The company has $13.34 million in cash and $104,522 in debt, giving a net cash position of $13.24 million or $0.14 per share.

Cash & Cash Equivalents	13.34M
Total Debt	104,522
Net Cash	13.24M
Net Cash Per Share	$0.14
Equity (Book Value)	8.66M
Book Value Per Share	0.10
Working Capital	8.62M

Cash Flow

In the last 12 months, operating cash flow was -$18.38 million and capital expenditures -$23,762, giving a free cash flow of -$18.00 million.

Operating Cash Flow	-18.38M
Capital Expenditures	-23,762
Free Cash Flow	-18.00M
FCF Per Share	-$0.19

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.77%
Shareholder Yield	-18.77%
Earnings Yield	-25.16%
FCF Yield	-16.45%

Analyst Forecast

The average price target for CRDL is $9.00, which is 669.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	669.23%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2